sulfites has been researched along with Astrocytoma, Grade IV in 6 studies
Sulfites: Inorganic salts of sulfurous acid.
sulfites : Any sulfurous acid derivative that is a salt or an ester of sulfurous acid.
organosulfonate oxoanion : An organic anion obtained by deprotonation of the sufonate group(s) of any organosulfonic acid.
sulfite : A sulfur oxoanion that is the conjugate base of hydrogen sulfite (H2SO3).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We created hypoxia using sodium sulfite (SS) for induction of substantiated autophagy in human GSC and glioblastoma SNB19 cells." | 7.83 | miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells. ( Chakrabarti, M; Klionsky, DJ; Ray, SK, 2016) |
| "The objective of this study was to report the authors' experience with the long-term administration of temozolomide (TMZ; > 6 cycles, up to 101) in patients with newly diagnosed glioblastoma and to analyze its feasibility and safety as well as its impact on survival." | 7.80 | Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. ( Albanese, V; Barbagallo, GM; Caltabiano, R; Certo, F; Lanzafame, S; Longo, A; Motta, F; Palmucci, S; Paratore, S; Parra, HS; Privitera, G; Scaglione, G, 2014) |
| " We created hypoxia using sodium sulfite (SS) for induction of substantiated autophagy in human GSC and glioblastoma SNB19 cells." | 3.83 | miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells. ( Chakrabarti, M; Klionsky, DJ; Ray, SK, 2016) |
| "The objective of this study was to report the authors' experience with the long-term administration of temozolomide (TMZ; > 6 cycles, up to 101) in patients with newly diagnosed glioblastoma and to analyze its feasibility and safety as well as its impact on survival." | 3.80 | Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. ( Albanese, V; Barbagallo, GM; Caltabiano, R; Certo, F; Lanzafame, S; Longo, A; Motta, F; Palmucci, S; Paratore, S; Parra, HS; Privitera, G; Scaglione, G, 2014) |
| "Gliomas are tumors of the central nervous system with a wide spectrum of different tumor types." | 1.32 | Distinct methylation profiles of glioma subtypes. ( Laird, PW; Marczinek, K; Nürnberg, P; Rohde, K; Szymas, J; Thiel, G; Uhlmann, K; Vogel, S; Zeller, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tierling, S | 1 |
| Jürgens-Wemheuer, WM | 1 |
| Leismann, A | 1 |
| Becker-Kettern, J | 1 |
| Scherer, M | 1 |
| Wrede, A | 1 |
| Breuskin, D | 1 |
| Urbschat, S | 1 |
| Sippl, C | 1 |
| Oertel, J | 1 |
| Schulz-Schaeffer, WJ | 1 |
| Walter, J | 1 |
| Barbagallo, GM | 1 |
| Paratore, S | 1 |
| Caltabiano, R | 1 |
| Palmucci, S | 1 |
| Parra, HS | 1 |
| Privitera, G | 1 |
| Motta, F | 1 |
| Lanzafame, S | 1 |
| Scaglione, G | 1 |
| Longo, A | 1 |
| Albanese, V | 1 |
| Certo, F | 1 |
| Chakrabarti, M | 1 |
| Klionsky, DJ | 1 |
| Ray, SK | 1 |
| Wolf, A | 1 |
| Agnihotri, S | 1 |
| Munoz, D | 1 |
| Guha, A | 1 |
| Uhlmann, K | 1 |
| Rohde, K | 1 |
| Zeller, C | 1 |
| Szymas, J | 1 |
| Vogel, S | 1 |
| Marczinek, K | 1 |
| Thiel, G | 1 |
| Nürnberg, P | 1 |
| Laird, PW | 1 |
| Mikeska, T | 1 |
| Bock, C | 1 |
| El-Maarri, O | 1 |
| Hübner, A | 1 |
| Ehrentraut, D | 1 |
| Schramm, J | 1 |
| Felsberg, J | 1 |
| Kahl, P | 1 |
| Büttner, R | 1 |
| Pietsch, T | 1 |
| Waha, A | 1 |
6 other studies available for sulfites and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics.
Topics: Brain Neoplasms; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Hum | 2022 |
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms | 2014 |
miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.
Topics: Acridine Orange; Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis R | 2016 |
Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme.
Topics: Animals; Brain; Brain Chemistry; Brain Neoplasms; Cell Line; Central Nervous System; CpG Islands; DN | 2011 |
Distinct methylation profiles of glioma subtypes.
Topics: Adolescent; Adult; Aged; Astrocytoma; Brain; Brain Neoplasms; Central Nervous System Neoplasms; Chil | 2003 |
Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.
Topics: Algorithms; Biomarkers, Tumor; Cluster Analysis; DNA Methylation; DNA Modification Methylases; DNA R | 2007 |